Dr. Gebeyehu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Medical Center Blvd
Winston Salem, NC 27157Phone+1 336-716-2011
Summary
- Dr. Rediet Gebeyehu is a Clinical Fellow in Hematology Oncology at Atrium Health WakeForest Baptist. She completed her Hospice Palliative care Fellowship and Internal Medicine Residency Program at Wellstar Health System in Atlanta,GA.
Education & Training
- Wake Forest University Baptist Medical CenterFellowship, Hematology and Medical Oncology, 2021 - 2024
- Wellstar Health System/Wellstar Kennestone Regional Medical CenterFellowship, Hospice and Palliative Medicine, 2020 - 2021
- Wellstar Health System/Wellstar Cobb HospitalResidency, Internal Medicine, 2014 - 2017
- Addis Ababa University Faculty of MedicineClass of 2010
Certifications & Licensure
- NC State Medical License 2021 - 2025
- GA State Medical License 2017 - 2022
- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Quad Shot Radiotherapy in Combination With Immune Checkpoint Inhibition Start of enrollment: 2021 Feb 25
Publications & Presentations
PubMed
- 83 citationsWho is telling the story? A systematic review of authorship for infectious disease research conducted in Africa, 1980–2016Rose Mbaye, Redeat Gebeyehu, Stefanie Hossmann, Nicole Fouda Mbarga, Estella Bih-Neh
BMJ Global Health. 2019-10-01 - 5 citationsMilitary exposures and lung cancer in United States Veterans.William Grier, Hatoon Abbas, Rediet Regassa Gebeyehu, Ankur Kumar Singh, Jimmy Ruiz
Seminars in Oncology. 2022-06-01 - 1 citationsQuad-shot-immunotherapy: quad-shot radiotherapy with pembrolizumab for advanced/recurrent head and neck cancer.Ryan T Hughes, Rediet R Gebeyehu, John Mason Kalada, Thomas W Lycan, Bart A Frizzell
Future Oncology. 2023-07-01
Abstracts/Posters
- Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell ca...Kimberly M Burcher 1, Chance H Bloomer 1, Elena Gavrila 2, John M Kalada 1, Mark J Chang 1, Rediet R Gebeyehu 3, Alexander H Song 3, Lara M Khoury 1, Thomas W Lycan 3 ..., Therapeutic advances in medical Oncology
- UTILIZATION OF 4T PRETEST PROBABILITY SCORING SYSTEM IN HEPARIN-INDUCED THROMBOCYTOPENIA AT WELLSTAR ATLANTA MEDICAL CENTER: A QUALITY IMPROVEMENT STUDYRediet Gebeyehu, Aderajew Tadesse, Getnet Tioum, Douglass Collins and Admasu Taddesse Wellstar Atlanta Medical Center, Atlanta, GA, U.S.A., ABSTRACTS OF THE 7TH INTERNATIONAL CONFERENCE ON ADVANCES IN HEMATOLOGY AND ONCOLOGY (ICAHO2019), 29-30 June, 2019, Issaquah, WA, USA, 6/29/2019
- The Path to Recovery from Malignant Status EpilepticusJobira Woldemichael, MD; Atlanta Medical Center, Atlanta, GA Ngozika Orjioke, MD, FCCP; Atlanta Medical Center, Atlanta, GA Eltrimizi Mohammed, MD; Atlanta Medical Cen..., 16th Annual Southern Hospital Medicine Conference Abstracts, Ochsner J. 2016 Spring; 16(1): e1–e42, 2016
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: